Bioline Rx (YP2A.F) Q4 2024 Earnings

25NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.02
-0.01
-0.01
0

Details

Expected EPS
-0.0027654848900000003
Actual EPS
0
Surprise EPS
0
Surprise Percent
+100%

Description

Bioline Rx (YP2A.F) will report earnings of for Q4 2024 on November 25, 2024.

0 Comments

Share your thoughts